Recent SRZN News
- Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling • GlobeNewswire Inc. • 06/12/2024 12:30:36 PM
- Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan • GlobeNewswire Inc. • 06/10/2024 12:30:01 PM
- Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis • GlobeNewswire Inc. • 06/04/2024 12:30:16 PM
- Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting • GlobeNewswire Inc. • 05/09/2024 12:30:24 PM
- Surrozen Provides First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/08/2024 08:05:00 PM
- Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis • GlobeNewswire Inc. • 04/03/2024 12:40:07 PM
- Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043 • GlobeNewswire Inc. • 04/01/2024 12:30:54 PM
- Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/01/2024 12:30:11 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/07/2024 11:16:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 11:10:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/22/2024 10:24:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 01:41:46 PM
- Surrozen Provides Corporate Update on Clinical Programs • GlobeNewswire Inc. • 01/18/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 02:26:15 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/13/2023 10:21:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:14:53 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/11/2023 09:11:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:08:09 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2023 09:27:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:17:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:09:25 PM
- Surrozen Provides Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/24/2023 08:23:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/24/2023 08:18:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/13/2023 08:51:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM